Chord Therapeutics
Developing drugs for patients with rare, life-threatening, and severely disabling diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€58—87m (Dealroom.co estimates Oct 2020.)
Company register number CHE-284.001.182
Geneva Canton of Geneva (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
$16.0m | Series A | ||
* | N/A | Acquisition | |
| Total Funding | €14.5m | ||
Related Content
Recent News about Chord Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.